A Novel Cuproptosis-Associated Gene Signature to Predict Prognosis in Patients with Pancreatic Cancer

Figure 8

Validation of the Cox risk model and risk genes: (a) univariate Cox analysis based on the GEO dataset was used to assess the impact of the risk score and risk genes on the prognosis of PAAD patients; (b) the differences in survival time of PAAD patients between the high- and low-risk groups in the GEO dataset; (c) in vitro validation of risk gene expression by qRT-PCR in normal pancreatic cells and PAAD cells. PAAD: pancreatic cancer; CG: control group.

(a)

(b)

(c)